David Guay, PhDResearch Director at Feldan TherapeuticsSpeaker
Profile
David Guay is the Research Director at Feldan Therapeutics since 2009. Dr. Guay received his PhD in molecular and cell biology from Laval University for its research on the implication of a transcription factor in DNA repair and chemotherapy resistance mechanisms. He holds a postdoctoral fellowship in chemical engineering from McGill University where he developed a DNA delivery technique based on a non-thermal plasma technology. His research at Feldan Therapeutics focuses on the “Feldan Shuttle”, a peptide-based technology designed to deliver native proteins, namely transcription factors, antibodies and CRISPR nucleases, in therapeutic cells.
Agenda Sessions
Engineered Amphiphilic Peptides Enable Delivery of CRISPR-associated Nucleases to Airway Epithelial Cells
On Demand - Premium OnlyView Session